Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.
2.

A naturalistic study of paroxetine in premenstrual syndrome: efficacy and side-effects during ten cycles of treatment.

Sundblad C, Wikander I, Andersch B, Eriksson E.

Eur Neuropsychopharmacol. 1997 Aug;7(3):201-6.

PMID:
9213079
3.

[Psychiatric and psychological aspects of premenstrual syndrome].

Limosin F, Ades J.

Encephale. 2001 Nov-Dec;27(6):501-8. Review. French.

PMID:
11865558
4.

Short onset of action of a serotonin reuptake inhibitor when used to reduce premenstrual irritability.

Landén M, Erlandsson H, Bengtsson F, Andersch B, Eriksson E.

Neuropsychopharmacology. 2009 Feb;34(3):585-92. doi: 10.1038/npp.2008.86. Epub 2008 Jul 2.

5.

Paroxetine controlled release for premenstrual dysphoric disorder: a double-blind, placebo-controlled trial.

Cohen LS, Soares CN, Yonkers KA, Bellew KM, Bridges IM, Steiner M.

Psychosom Med. 2004 Sep-Oct;66(5):707-13.

PMID:
15385695
6.

Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder.

Landén M, Nissbrandt H, Allgulander C, Sörvik K, Ysander C, Eriksson E.

Neuropsychopharmacology. 2007 Jan;32(1):153-61. Epub 2006 Oct 11.

7.
8.

Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity.

Atkinson JH, Slater MA, Wahlgren DR, Williams RA, Zisook S, Pruitt SD, Epping-Jordan JE, Patterson TL, Grant I, Abramson I, Garfin SR.

Pain. 1999 Nov;83(2):137-45.

PMID:
10534584
9.

Double-blind, placebo-controlled pilot study of adjunctive quetiapine SR in the treatment of PMS/PMDD.

Jackson C, Pearson B, Girdler S, Johnson J, Hamer RM, Killenberg S, Meltzer-Brody S.

Hum Psychopharmacol. 2015 Nov;30(6):425-34. doi: 10.1002/hup.2494. Epub 2015 Jul 19.

PMID:
26193781
10.

Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria.

Eriksson E.

Int Clin Psychopharmacol. 1999 May;14 Suppl 2:S27-33. Review.

PMID:
10471170
11.

Luteal phase administration of paroxetine for the treatment of premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled trial in Canadian women.

Steiner M, Ravindran AV, LeMelledo JM, Carter D, Huang JO, Anonychuk AM, Simpson SD.

J Clin Psychiatry. 2008 Jun;69(6):991-8.

PMID:
18517289
12.

The efficacy of Hypericum perforatum (St John's wort) for the treatment of premenstrual syndrome: a randomized, double-blind, placebo-controlled trial.

Canning S, Waterman M, Orsi N, Ayres J, Simpson N, Dye L.

CNS Drugs. 2010 Mar;24(3):207-25. doi: 10.2165/11530120-000000000-00000.

PMID:
20155996
13.

Response to treatment in minor and major depression: results of a double-blind comparative study with paroxetine and maprotiline.

Szegedi A, Wetzel H, Angersbach D, Philipp M, Benkert O.

J Affect Disord. 1997 Sep;45(3):167-78.

PMID:
9298430
14.

Selective serotonin reuptake inhibitors for premenstrual syndrome.

Brown J, O' Brien PM, Marjoribanks J, Wyatt K.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD001396. doi: 10.1002/14651858.CD001396.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;6:CD001396.

PMID:
19370564
15.
16.

Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.

Freeman EW, Rickels K, Sondheimer SJ, Polansky M.

Arch Gen Psychiatry. 1999 Oct;56(10):932-9.

PMID:
10530636
17.

Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial.

Sundblad C, Modigh K, Andersch B, Eriksson E.

Acta Psychiatr Scand. 1992 Jan;85(1):39-47.

PMID:
1546547
18.

Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.

Shah NR, Jones JB, Aperi J, Shemtov R, Karne A, Borenstein J.

Obstet Gynecol. 2008 May;111(5):1175-82. doi: 10.1097/AOG.0b013e31816fd73b.

19.

Paroxetine as a treatment for premenstrual dysphoric disorder.

Yonkers KA, Gullion C, Williams A, Novak K, Rush AJ.

J Clin Psychopharmacol. 1996 Feb;16(1):3-8.

PMID:
8834412
20.

Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.

Halbreich U, Smoller JW.

J Clin Psychiatry. 1997 Sep;58(9):399-402.

PMID:
9378691
Items per page

Supplemental Content

Write to the Help Desk